IonQ Insider: Inder M. Singh Exercises Options and Sells Shares at $43.02

Rhea-AI Filing Summary

Insider transactions by Director Inder M. Singh at IonQ (IONQ)

On 08/13/2025 Inder M. Singh executed multiple option-related transactions and a sale. He acquired 33,570 shares at $12.93, 2,050 shares at $5.72, and 14,860 shares at $13.53 through option-related actions. On the same date he sold 50,480 shares at a weighted-average price of $43.023. After these transactions the report shows the Reporting Person beneficially owned 5,513 shares. The filing notes all option shares were fully vested and exercisable as of the transaction date and that the sale price range was $42.97 to $43.16.

Positive

• All option shares were fully vested and exercisable as of the transaction date, per the filing
• Sale executed at a weighted-average price of $43.023, substantially above the exercised strike prices

Negative

• Large net disposition: 50,480 shares were sold, reducing beneficial ownership to 5,513 shares
• Significant insider monetization on the same date as option exercises, which reduces the director's direct shareholding

Insights

Securities Analyst

TL;DR: Director exercised vested options and sold most resulting shares at a weighted-average $43.023, leaving a small residual holding.

The filing documents routine option exercises followed by an immediate or near-term sale of shares. The acquisitions at strike prices $5.72, $12.93 and $13.53 reflect option exercises or option-related acquisitions, with the sale executed at a weighted-average price materially above those strikes. This pattern realizes gains for the reporting person and reduces his direct shareholding to 5,513 shares. From a market-impact perspective this is an insider monetization event rather than a new capital allocation or governance change; it is material to monitor but is consistent with compensation exercise and sale.

Corporate Governance Expert

TL;DR: Transaction pattern is consistent with vested-option exercise and monetization; no governance or control change is indicated.

The disclosure explicitly states all option shares were fully vested and exercisable as of the transaction date. The report is filed individually by the reporting person and indicates no change in director status. The large sale reduces direct beneficial ownership to a single-digit share count (5,513), which is a fact investors may note when assessing insider alignment, but the filing does not show any additional pledging, transfers to affiliates, or changes in board relationship.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Singh Inder M

(Last) (First) (Middle)

C/O IONQ, INC.

4505 CAMPUS DRIVE

(Street)

COLLEGE PARK MD 20740

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IonQ, Inc. [ IONQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/13/2025		M		33,570	A	$12.93	39,083	D
Common Stock	08/13/2025		M		2,050	A	$5.72	41,133	D
Common Stock	08/13/2025		M		14,860	A	$13.53	55,993	D
Common Stock	08/13/2025		S		50,480	D	$43.023(1)	5,513	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$12.93	08/13/2025		M			33,570	(2)	01/14/2032	Common Stock	33,570	$12.93	0	D
Stock Option (right to buy)	$5.72	08/13/2025		M			2,050	(2)	05/25/2032	Common Stock	32,050	$5.72	10,000	D
Stock Option (right to buy)	$13.53	08/13/2025		M			14,860	(2)	06/30/2033	Common Stock	14,860	$13.53	0	D

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.97 to $43.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

2. All of the shares subject to this option are fully vested and exercisable as of the date hereof

	/s/ Kevin Caimi, Attorney-in-Fact	08/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for IONQ and what is their role?

The Form 4 was filed for Inder M. Singh, who is identified in the filing as a Director of IonQ.

What transactions did Inder M. Singh report on 08/13/2025?

He reported acquisitions of 33,570, 2,050, and 14,860 shares via option-related transactions and a sale of 50,480 shares.

At what price were the shares sold and what was the price range?

The sale was reported at a weighted-average price of $43.023; the filing states individual sale prices ranged from $42.97 to $43.16.

What strike/exercise prices were reported for the option-related acquisitions?

The reported prices (conversion/exercise or acquisition prices) were $12.93, $5.72, and $13.53 for the respective option-related acquisitions.

How many shares does the reporting person beneficially own after these transactions?

The filing shows the reporting person beneficially owned 5,513 shares following the reported transactions.